NCT03150810
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Phase 1|Phase 2
Drug Category: Misc Inhibitor, Chemotherapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years to 99 Years (Adult), Senior)
Location of Metastases: 
Additional Notes: 
Exclusions: Untreated leptomeningeal or brain metastasis
https://ClinicalTrials.gov/show/NCT03150810